Atrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited: A Population-Based Study, Stroke, vol.44, issue.11, pp.3103-3111, 2013. ,
Prospective National Study of the Prevalence, Incidence, Management and Outcome of a Large Contemporary Cohort of Patients With Incident Non-Valvular Atrial Fibrillation, J Am Heart Assoc. 21 janv, vol.4, issue.1, pp.1486-001486, 2015. ,
Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study, Circulation. 23 août, vol.110, issue.9, pp.1042-1048, 2004. ,
incidence and lifetime risk of atrial fibrillation: the Rotterdam study, Eur Heart J. 8 août, vol.27, issue.8, pp.949-53, 2005. ,
Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease, Study. Circulation. 25 févr, vol.129, issue.8, pp.837-884, 2010. ,
Epidemiology of atrial fibrillation: European perspective, Clin Epidemiol. juin, p.213, 2014. ,
An Update on the Prognosis of Patients With Atrial Fibrillation. Circulation. 4 sept, vol.126, pp.143-149, 2012. ,
Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century, Int J Cardiol. sept, vol.167, issue.5, pp.1807-1831, 2013. ,
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available, Am J Cardiol. oct, vol.82, issue.7, pp.2-9, 1998. ,
Review of epidemiology and management of atrial fibrillation in developing countries, Int J Cardiol. sept, vol.167, issue.6, pp.2412-2432, 2013. ,
Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries: The RE-LY Atrial Fibrillation Registry, Circulation. 15 avr, vol.129, issue.15, pp.1568-76, 2014. ,
Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population, Am J Cardiol. oct, vol.112, issue.8, pp.1142-1149, 2013. ,
Projections on the number of individuals with atrial fibrillation in the European Union, Eur Heart J. 1 sept, vol.34, issue.35, pp.2746-51, 2000. ,
Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study, Circulation. 17 juin, vol.107, issue.23, pp.2920-2925, 2003. ,
Detection of Atrial Fibrillation After Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis, Stroke. 1 févr, vol.45, issue.2, pp.520-526, 2014. ,
Cryptogenic Stroke and Underlying Atrial Fibrillation, N Engl J Med. 26 juin, vol.370, issue.26, pp.2478-86, 2014. ,
50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study, The Lancet. juill, vol.386, issue.9989, pp.154-62, 2015. ,
Allcause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study, Eur Heart J. 7 avr, vol.34, issue.14, pp.1061-1068, 2013. ,
Impact of Atrial Fibrillation on the Risk of Death : The Framingham Heart Study, Circulation. 8 sept, vol.98, issue.10, pp.946-52, 1998. ,
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study, Am J Med, vol.113, issue.5, pp.359-64, 2002. ,
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke. 1 août, vol.22, issue.8, pp.983-991, 1991. ,
The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the manitoba follow-up study, Am J Med. mai, vol.98, issue.5, pp.476-84, 1995. ,
Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies, Can Med Assoc J. 3 avr, vol.184, issue.6, pp.329-365, 2012. ,
Atrial Fibrillation and Dementia in a Population-Based Study: The Rotterdam Study, Stroke. 1 févr, vol.28, issue.2, pp.316-337, 1997. ,
Quality of Life in Patients with Atrial Fibrillation: A Systematic Review, Am J Med. mai, vol.119, issue.5, pp.448-449, 2006. ,
Depressed mood amplifies heart-related symptoms in persistent and paroxysmal atrial fibrillation patients: a longitudinal analysis-data from the German Competence Network on Atrial Fibrillation, Europace. sept, vol.17, issue.9, pp.1354-62, 2015. ,
Management of Patients With Atrial Fibrillation by Primary-Care Physicians in Germany: 1-Year Results of the ATRIUM Registry: Management of AF in clinical practice, Clin Cardiol. mai, vol.37, issue.5, pp.277-84, 2014. ,
Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF), Am Heart J. mai, vol.167, issue.5, pp.735-742, 2014. ,
La fibrillation atriale en 2010 : un poids croissant sur la morbidité et la mortalité cardiovasculaires, Ann Cardiol Angéiologie. déc, vol.59, pp.4-13, 2010. ,
DOI : 10.1016/s0003-3928(10)70002-0
Histological substrate of human atrial fibrillation, Biomed Pharmacother. mars, vol.64, issue.3, pp.177-83, 2010. ,
Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipofibrokines, Eur Heart J. 1 avr, vol.36, issue.13, pp.795-805, 2015. ,
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation, Ann Intern Med. 19 juin, vol.146, issue.12, p.857, 2007. ,
DOI : 10.7326/0003-4819-146-12-200706190-00007
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials, The Lancet. mars, vol.383, issue.9921, pp.955-62, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-00935589
Improving outcomes in patients with atrial fibrillation: Rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial, Am Heart J. sept, vol.166, issue.3, pp.442-450, 2013. ,
Rateand Rhythm-Control Therapies in Patients With Atrial Fibrillation: A Systematic Review, Ann Intern Med. 3 juin, vol.160, issue.11, p.760, 2014. ,
Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation, Ann Intern Med, vol.16, issue.8, pp.590-592, 2007. ,
20 mg cp quadriséc-Pharmacodynamie ,
,
Dabigatran versus Warfarin in Patients with Atrial Fibrillation, N Engl J Med. 17 sept, vol.361, issue.12, pp.1139-51, 2009. ,
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation, N Engl J Med. 8 sept, vol.365, issue.10, pp.883-91, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01038111
Apixaban versus Warfarin in Patients with Atrial Fibrillation, N Engl J Med. 15 sept, vol.365, issue.11, pp.981-92, 2011. ,
Améliorations pharmacologiques apportées par les nouveaux anticoagulants oraux, Presse Médicale. sept, vol.42, issue.9, pp.1206-1218, 2013. ,
DOI : 10.1016/j.lpm.2013.06.008
A 1:1 PROPENSITYSCORE MATCHED ANALYSIS, J Am Coll Cardiol. avril, vol.67, issue.13_S, pp.882-882, 2016. ,
A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants, Eur Heart J-Cardiovasc Pharmacother. 23 sept, p.31, 2016. ,
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation, J Am Heart Assoc. juin, vol.5, issue.6, p.3725, 2016. ,
Comparative Efficacy and Safety of the Non-Vitamin K Antagonist Oral Anticoagulants for Patients with Nonvalvular Atrial Fibrillation, Semin Thromb Hemost. 15 févr, vol.41, issue.02, pp.146-53, 2015. ,
Edoxaban versus Warfarin in Patients with Atrial Fibrillation, N Engl J Med, vol.369, issue.22, pp.2093-104, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00934699
Adherence to Long-term Therapies: Evidence for Action. World Health Organization, vol.230, 2003. ,
Medication Adherence: Its Importance in Cardiovascular Outcomes, Circulation. 16 juin, vol.119, issue.23, pp.3028-3063, 2009. ,
Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation, J Am Heart Assoc. févr, vol.5, issue.2, p.3074, 2016. ,
Adherence in outpatients taking warfarin and its effect on anticoagulation control in Jordan, Int J Clin Pharm. août, vol.38, issue.4, pp.816-837, 2016. ,
Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurrence, Stroke. 1 sept, vol.42, issue.9, pp.2509-2523, 2011. ,
The Influence of Patient Adherence on Anticoagulation Control With Warfarin: Results From the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study, Arch Intern Med. 12 févr, vol.167, issue.3, p.229, 2007. ,
Adherence to Medication, N Engl J Med. 4 août, vol.353, issue.5, pp.487-97, 2005. ,
Adherence to oral anticoagulants in patients with atrial fibrillation-a population-based retrospective cohort study linking health information systems in the Valencia region, Spain: a study protocol, BMJ Open. 10 janv, vol.5, issue.10, p.7613, 2015. ,
Development of a Conceptual Model of Adherence to Oral Anticoagulants to Reduce Risk of Stroke in Patients with Atrial Fibrillation, J Manag Care Pharm. juin, vol.18, issue.5, pp.351-62, 2012. ,
Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data, Europace. 1 févr, vol.17, issue.2, pp.187-93, 2011. ,
Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure, Curr Med Res Opin. déc, vol.31, issue.12, pp.2167-73, 2015. ,
Disadvantages of VKA and requirements for novel anticoagulants, Best Pract Res Clin Haematol. juin, vol.26, issue.2, pp.103-117, 2013. ,
Drug Adherence in Patients With Nonvalvular Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants in Turkey: NOAC-TR, Clin Appl Thromb. janv, p.107602961769394, 2017. ,
Adherence to oral anticoagulant therapy in secondary stroke prevention – impact of the novel oral anticoagulants. Patient Prefer Adherence, p.1695, 2015. ,
Frequency and Determinants of Adherence to Oral Anticoagulants in Stroke Patients with Atrial Fibrillation in Clinical Practice, Eur Neurol, vol.76, issue.3-4, pp.187-93, 2016. ,
Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation, J Manag Care Spec Pharm, vol.22, issue.11, pp.1319-1348, 2016. ,
Agir mais ne rien changer ? De l'utilisation des expériences pilotes en gestion de l'environnement. VertigO, 2009. ,
,
Education thérapeutique du patient en médecine générale (représentations, pratiques et attentes des praticiens de la Somme), 2008. ,
, HAS, commission de transparence. GUIDE PARCOURS DE SOINS-Fibrillation atriale, 2014.
La perception des médecins généralistes par rapport à l'utilisation des AOD (anticoagulants oraux directs): enquête qualitative en Charente, 2016. ,
Les nouveaux anticoagulants oraux: entre révolution thérapeutique et vigilance, 2012. ,
Évaluation des pratiques des médecins généralistes sur la prescription des anticoagulants oraux directs (dabigatran pradaxa®, rivaroxaban xarelto® et apixaban eliquis®) chez les personnes âgées de plus de 75 ans sur le secteur sanitaire palois, 2014. ,
Les nouveaux anticoagulants oraux (NACO) (Dabigatran, rivaroxaban): ressenti des médecins généralistes picards sur leurs utilisations et leurs perspectives, 2013. ,
Etude sur la prescription des nouveaux anticoagulants oraux chez les médecins généralistes picards, 2013. ,
Prescription des anticoagulants oraux en médecine générale: étude de pratiques comparant la gestion des anticoagulants oraux directs et des antivitamines k par des médecins généralistes girondins, 2014. ,
Les prescripteurs face aux nouveaux anticoagulants oraux, J Mal Vasc, vol.38, issue.5, pp.320-321, 2013. ,
Les nouveaux anticoagulants oraux vus par les médecins généralistes, 2013. ,
Perception de l'utilisation des anticoagulants oraux directs: enquêtes auprès des médecins généralistes, 2012. ,
Utilisation des anticoagulants oraux en médecine générale en Haute, 2015. ,
Ressenti des médecins généralistes sur les anticoagulants oraux directs: enquête qualitative auprès de neuf médecins en Loire Atlantique, 2015. ,
Ressenti des médecins généralistes face aux anticoagulants oraux directs, 2012. ,
Les nouveaux anticoagulants oraux en médecine générale: modalités de prescription et perception par les généralistes. France, 2014. ,
Identification des facteurs associés à la prescription d'un anticoagulant oral direct en médecine générale, vol.80, 2015. ,
Predictive Validity of a Medication Adherence Measure in an Outpatient Setting, J Clin Hypertens. mai, vol.10, issue.5, pp.348-54, 2008. ,
Validation of a French Version of the 8-Item Morisky Medication Adherence Scale in Hypertensive Adults, J Clin Hypertens. juillet, vol.14, issue.7, pp.429-463, 2012. ,
Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin, Thromb Haemost, vol.108, issue.4, pp.789-95, 2012. ,
Comparison of three medication adherence measures in patients taking warfarin, J Thromb Thrombolysis, vol.36, issue.4, pp.416-437, 2013. ,
The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients, Health Qual Life Outcomes, vol.10, issue.1, p.120, 2012. ,
Patient-Reported Treatment Satisfaction with Rivaroxaban for Stroke Prevention in Atrial Fibrillation. A French Observational Study, the SAFARI Study. Pizzi C, éditeur, PLOS ONE. 9 déc, vol.11, issue.12, p.166218, 2016. ,
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach, Chest. févr, vol.137, issue.2, pp.263-72, 2010. ,
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation. Chest, vol.138, pp.1093-100, 2010. ,
Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium, Circulation. 14 juin, vol.123, issue.23, pp.2736-2783, 2011. ,
Reversal of direct oral anticoagulants. Vasc Health Risk Manag, vol.13, pp.287-92, 2017. ,
Reversal of Newer Direct Oral Anticoagulant Drugs (DOACs), Cardiovasc Hematol Agents Med Chem. 18 janv, vol.14, issue.2, pp.76-81, 2017. ,
Specific antidotes in development for reversal of novel anticoagulants: a review. Recent Patents Cardiovasc Drug Discov, vol.9, pp.2-10, 2014. ,
Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data, Int J Cardiol. juill, vol.214, pp.292-300, 2016. ,
Management and Outcomes of Bleeding Events in Patients in the Emergency Department Taking Warfarin or a Non-Vitamin K Antagonist Oral Anticoagulant, J Emerg Med, p.17, 2016. ,
,
Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study, Eur Heart J, p.496, 2016. ,
New Oral Anticoagulants in Elderly Adults: Evidence from a Meta-Analysis of Randomized Trials, J Am Geriatr Soc. mai, vol.62, issue.5, pp.857-64, 2014. ,
Novel Oral Anticoagulants in Patients With Renal Insufficiency: A Meta-analysis of Randomized Trials, Can J Cardiol. août, vol.30, issue.8, pp.888-97, 2014. ,
Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic deep-vein thrombosis, Thromb Haemost. 11 juill, vol.110, issue.4, pp.732-773, 2013. ,
Adherence with oral anticoagulation in non-valvular atrial fibrillation: a comparison of vitamin K antagonists and non-vitamin K antagonists, Eur Heart J-Cardiovasc Pharmacother. juill, vol.3, issue.3, pp.151-157, 2017. ,
Anticoagulants d'action directe: une revue de la littérature des études coût/efficacité en Europe, Arch Cardiovasc Dis Suppl. février, vol.8, issue.2, pp.180-91, 2016. ,
,
, Enquête nationale : effectifs étudiants, enseignants, nombre de stage en médecine générale, 2014.
, des arrivées toujours plus nombreuses-Insee Analyses, 2017.
Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration, BMC Cardiovasc Disord, vol.17, issue.1, p.11, 2017. ,
Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation, Expert Opin Drug Saf. 2 sept, vol.16, issue.9, pp.1051-62, 2017. ,
Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States, Circ Cardiovasc Qual Outcomes. 1 mai, vol.4, issue.3, pp.313-333, 2011. ,
Self-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scale, Thromb Res, vol.136, issue.4, pp.727-758, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01259485
Assessment of Patient Adherence to Direct Oral Anticoagulant vs Warfarin Therapy, J Am Osteopath Assoc. 1 janv, vol.117, issue.1, p.7, 2017. ,
Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a French nationwide cohort study, Pharmacoepidemiol Drug Saf, p.11, 2017. ,
,
Patient adherence to warfarin therapy and its impact on anticoagulation control, Saudi Pharm J SPJ. janv, vol.24, issue.1, pp.29-34, 2016. ,
DOI : 10.1016/j.jsps.2015.02.005
URL : https://doi.org/10.1016/j.jsps.2015.02.005
Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection, J Gen Intern Med. nov, vol.19, issue.11, pp.1096-103, 2004. ,
Physicians' characteristics influence patients' adherence to medical treatment: Results from the Medical Outcomes Study, Health Psychol, vol.12, issue.2, pp.93-102, 1993. ,
The role of the primary care physician in patients' adherence to antidepressant therapy, Med Care. janv, vol.33, issue.1, pp.67-74, 1995. ,
Impact of Fixed-Dose Combination Drugs on Adherence to Prescription Medications, J Gen Intern Med. mai, vol.23, issue.5, pp.611-615, 2008. ,
Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation, Clin Ther, vol.38, issue.11, pp.2477-88, 2016. ,
Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism, Patient-Patient-Centered Outcomes Res. sept, vol.6, issue.3, pp.213-237, 2013. ,
Impact of Daily Dosing Frequency on Adherence to Chronic Medications Among Nonvalvular Atrial Fibrillation Patients, Adv Ther. août, vol.29, issue.8, pp.675-90, 2012. ,
Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation: Results From the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF), Circulation. 6 mai, vol.129, issue.18, pp.1850-1859, 2014. ,
, Fibrillation auriculaire non valvulaire, quelle place pour les anticoagulants oraux?, Juillet, 2013.
Review of the four item Morisky Medication Adherence Scale (MMAS4) and eight item Morisky Medication Adherence Scale (MMAS-8), Innov Pharm [Internet]. 1 janv, vol.5, issue.3, 2014. ,
, , p.12, 2017.
ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur Heart J, vol.37, issue.38, pp.2893-962, 2016. ,
, Sauf en cas de refus de votre part, vous serez destinataire des résultats de cette recherche. Les questionnaires sont à renvoyer par Fax ou courrier
, Cette étude a été approuvée au préalable par un comité de protection des personnes. Cordialement. Paul LEMIERE Coordonnées : 06.22.92.31.66 ; paul.lemiere@yahoo.fr Adresse de renvoi : CHICAS Gap service de cardiologie 1
Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), Eur Heart J, vol.31, pp.2369-429, 2010. ,
Predictive Validity of a Medication Adherence Measure in an Outpatient Setting, J Clin Hypertens, vol.10, issue.5, pp.348-54, 2008. ,
, Stratégies d'amélioration de l'adhérence à un traitement
Adherence to Medication, N Engl J Med. 4 août, vol.353, issue.5, pp.487-97, 2005. ,